249 related articles for article (PubMed ID: 28472421)
1. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
3. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
[TBL] [Abstract][Full Text] [Related]
4. An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity.
Baseler LJ; Falzarano D; Scott DP; Rosenke R; Thomas T; Munster VJ; Feldmann H; de Wit E
Am J Pathol; 2016 Mar; 186(3):630-8. PubMed ID: 26724387
[TBL] [Abstract][Full Text] [Related]
5. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset.
de Wit E; Feldmann F; Horne E; Okumura A; Cameroni E; Haddock E; Saturday G; Scott D; Gopal R; Zambon M; Corti D; Feldmann H
Antiviral Res; 2019 Mar; 163():70-74. PubMed ID: 30684561
[TBL] [Abstract][Full Text] [Related]
8. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
Han HJ; Liu JW; Yu H; Yu XJ
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets.
de Wit E; Feldmann F; Okumura A; Horne E; Haddock E; Saturday G; Scott D; Erlandson KJ; Stahl N; Lipsich L; Kyratsous CA; Feldmann H
Antiviral Res; 2018 Aug; 156():64-71. PubMed ID: 29885377
[TBL] [Abstract][Full Text] [Related]
11. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.
Coleman CM; Sisk JM; Halasz G; Zhong J; Beck SE; Matthews KL; Venkataraman T; Rajagopalan S; Kyratsous CA; Frieman MB
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795435
[TBL] [Abstract][Full Text] [Related]
13. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
Kim MH; Kim HJ; Chang J
PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
[TBL] [Abstract][Full Text] [Related]
14. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Ying T; Li H; Lu L; Dimitrov DS; Jiang S
Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
[TBL] [Abstract][Full Text] [Related]
15. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
Mubarak A; Alturaiki W; Hemida MG
J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
[TBL] [Abstract][Full Text] [Related]
16. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
Jiang L; Wang N; Zuo T; Shi X; Poon KM; Wu Y; Gao F; Li D; Wang R; Guo J; Fu L; Yuen KY; Zheng BJ; Wang X; Zhang L
Sci Transl Med; 2014 Apr; 6(234):234ra59. PubMed ID: 24778414
[TBL] [Abstract][Full Text] [Related]
17. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
Chen Y; Lu S; Jia H; Deng Y; Zhou J; Huang B; Yu Y; Lan J; Wang W; Lou Y; Qin K; Tan W
Emerg Microbes Infect; 2017 May; 6(5):e37. PubMed ID: 28536429
[TBL] [Abstract][Full Text] [Related]
18. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.
Lee JH; Kim JW; Lee HE; Song JY; Cho AH; Hwang JH; Heo K; Lee S
Virus Res; 2024 Jul; 345():199383. PubMed ID: 38697296
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
[TBL] [Abstract][Full Text] [Related]
20. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV.
Fan C; Wu X; Liu Q; Li Q; Liu S; Lu J; Yang Y; Cao Y; Huang W; Liang C; Ying T; Jiang S; Wang Y
Viruses; 2018 Aug; 10(9):. PubMed ID: 30142928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
